Cassie Jung Aquestive Therapeutics, Inc. (AQST) insider trading activity

Cassie Jung is Chief Operating Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 240,771 shares of AQST, which is worth approximately $1.7 Million. The most recent transaction as insider was on Oct 15, 2025, when has been sold 67,575 shares (Common Stock) at a price of $7.01 per share, resulting in proceeds of $473,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 241K

18.53% 3M change

1.27% 12M change

Total Value Held $1.7 Million

Cassie Jung Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	SELL Open market or private sale	$473,700 $7.01 p/Share	67,575 Reduced 21.92%	240,771 Common Stock
Oct 15 2025	BUY Exercise of conversion of derivative security	$77,500 $3.1 p/Share	25,000 Added 7.5%	308,346 Common Stock
Sep 04 2025	SELL Open market or private sale	$310,900 $5.0 p/Share	62,180 Reduced 18.0%	283,346 Common Stock
Sep 04 2025	BUY Exercise of conversion of derivative security	$96,500 $1.93 p/Share	50,000 Added 12.64%	345,526 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$5,542 $2.54 p/Share	2,182 Reduced 0.73%	295,526 Common Stock
Mar 09 2025	SELL Payment of exercise price or tax liability	$21,192 $2.65 p/Share	7,997 Reduced 2.62%	297,708 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$19,506 $2.65 p/Share	7,361 Reduced 2.35%	305,705 Common Stock
Mar 07 2025	BUY Grant, award, or other acquisition	-	80,000 Added 20.35%	313,066 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$5,524 $4.88 p/Share	1,132 Reduced 0.47%	237,754 Common Stock
Mar 09 2024	SELL Payment of exercise price or tax liability	$40,504 $4.88 p/Share	8,300 Reduced 3.36%	238,886 Common Stock
Mar 07 2024	BUY Grant, award, or other acquisition	-	101,250 Added 29.06%	247,186 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	-	1,365 Reduced 0.93%	145,936 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	-	110,000 Added 42.84%	146,747 Common Stock

Cassie Jung

Chief Operating Officer

Warren, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Value

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aquestive Therapeutics, Inc.

Track Activities on AQST

Account